European Companies Search Engine
No longer ppa (2) · MD (1) · No longer MD (2) · Profit Transfer: Bayer Schering Pharma AG · Control: Bayer Schering Pharma AG · Change of headquarters: Scheradmin 01 GmbH · Capital: €25,000 … Hrb 25 Apr 2007 German Trade Register Announcements, Germany (19/04/2007)
Overview
Text
Marotrast GmbH, Jena (
Unnamed street ??, 07745 Jena, Germany
). GmbH. Partnership agreement of October 5, 2004. The Shareholders' Meeting of February 13, 2007 decided to amend Section 1 (Company, previously Scheradmin 01 GmbH, and Registered Office, previously Berlin, Amtsgericht Charlottenburg (Berlin) HRB 94921 B), 2 (object of the company) paragraphs 1 and 4 (share capital) of the partnership agreement. The object of the company: the development, purchase and sale of medicinal products, in particular contrast agents for diagnostic imaging, as well as pharmaceutical active ingredients, intermediates and medical devices, as well as the performance of related services. Share capital: EUR 25,000.00. If only one managing director is appointed, he represents the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Retired: Managing Director: Dr. ???????, ?????, Berlin, *??.??.????; Dr. ??????, ?????, Berlin, *??.??.????. Appointed: Managing Director: Dr. ????????, ??????, Berlin, *??.??.????. Procura terminated: Dr. ??????????, ??????, Berlin, *??.??.????; ???????, ???????, Berlin, *??.??.????. There is a control and profit transfer agreement with Schering AG (Amtsgericht Charlottenburg (Berlin) HRB 283 B), which was approved by the Shareholders' Meeting by decision of May 24, 2005 and the annual general meeting of Schering AG by decision of April 14, 2005.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Marotrast GmbH, Jena, Germany.